Intrinsiqs

Is Telomir Pharmaceuticals, Inc. Common Stock overvalued?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) — key valuation metrics and fundamentals.

No verdict
Price
$1.23
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$84.6M
Dividend yield
0.0%
Return on equity
-102.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TELO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.